The new rule requires sponsors to report antimicrobial sales estimates that are species-specific. The resulting acquired data will complement larger information being gathered in collaboration with the CDC and the U.S. Department of Agriculture. The cooperative effort aims to reduce the prevalence of antibiotic resistant bacteria.
William T. Flynn, deputy director for science policy at the FDA’s Center for Veterinary Medicine, said, “This information will further enhance FDA’s ongoing activities related to slowing the development of antimicrobial resistance to help ensure that safe and effective antimicrobial new animal drugs will remain available for use in human and animal medicine.”
More articles on population health:
NYC says bartenders can’t refuse to serve pregnant women alcohol
NIH grants NYU $1.6 million to study biological and physiological effects of e-cigs
CDC report: 34% of American adults did not see, talk to a physician last year
